EVALUATION OF SALIVA AND SERUM HEME OXYGENASE, ARYLESTERASE AND NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2 LEVELS IN PATIENTS WITH STAGE III PERIODONTITIS

NCT06986044 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 74

Last updated 2025-05-22

No results posted yet for this study

Summary

Periodontal disease is a chronic and progressive inflammatory disease in which the hard and soft tissues that support the teeth are damaged. It is caused by the interaction between harmful bacteria and the body's immune responses, and most periodontal tissues are damaged by the body's abnormal response to these microorganisms and their products. When bacteria enter the body, immune cells (neutrophils) produce reactive oxygen species (ROS) in a process called the "respiratory burst". These ROS damage cells, causing tissue destruction through a variety of mechanisms, including DNA damage, fat oxidation and protein damage. Studies have shown that neutrophils from individuals with periodontal disease produce more ROS than neutrophils from healthy individuals. High amounts of ROS lead to oxidative damage to gum tissue, periodontal ligament and alveolar bone. Oxidative stress occurs when antioxidants in the body are insufficient or when high levels of ROS are present. Therefore, disruption of the balance between oxidant and antioxidant activities is considered an important cause of oxidative damage in periodontal tissues. Parameters such as total antioxidant status (TAS), total oxidant status (TOS) and oxidative stress index (OSI) are used to determine oxidative stress.

Furthermore, some enzymes such as arylesterase (ARE), heme oxygenase (HO) and nuclear factor erythroid 2-related factor 2 (NRF-2) are involved in defense mechanisms against oxidative stress. Many recent studies have shown a strong association between oxidative stress and periodontal disease.

Conditions

  • Periodontal Health
  • Periodontitis Stage III

Interventions

DIAGNOSTIC_TEST

Serum Total Oxidant Status

Serum total oxidant status

DIAGNOSTIC_TEST

Salivary Total Oxidant Status

Salivary Total Oxidant Status

DIAGNOSTIC_TEST

Serum Total Antioxidant Status

Serum Total Antioxidant Status

DIAGNOSTIC_TEST

Salivary Total Antioxidant Status

Salivary Total Antioxidant Status

DIAGNOSTIC_TEST

Serum Oxidative Stress Index

Serum Oxidative Stress Index

DIAGNOSTIC_TEST

Salivary Oxidative Stress Index

Salivary Oxidative Stress Index

DIAGNOSTIC_TEST

Serum Arylesterase

Serum Arylesterase

DIAGNOSTIC_TEST

Salivary Arylesterase

Salivary Arylesterase

DIAGNOSTIC_TEST

Serum Heme Oxygenase

Serum Heme Oxygenase

DIAGNOSTIC_TEST

Salivary Heme Oxygenase

Salivary Heme Oxygenase

DIAGNOSTIC_TEST

Serum Nuclear Factor Erythroid 2 Related Factor 2

Serum Nuclear Factor Erythroid 2 Related Factor 2

DIAGNOSTIC_TEST

Salivary Nuclear Factor Erythroid 2 Related Factor 2

Salivary Nuclear Factor Erythroid 2 Related Factor 2

DIAGNOSTIC_TEST

Gingival Index

Gingival Index

DIAGNOSTIC_TEST

Plaque Index

Plaque Index

DIAGNOSTIC_TEST

Bleeding on Probing Index

Bleeding on Probing Index

DIAGNOSTIC_TEST

Clinical Attachment Loss

Clinical Attachment Loss

DIAGNOSTIC_TEST

Pocket Deep

Pocket Deep

Sponsors & Collaborators

  • Saglik Bilimleri Universitesi

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2024-05-01
Completion
2024-09-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06986044 on ClinicalTrials.gov